135 related articles for article (PubMed ID: 8565230)
21. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
Milano G; Thyss A; Renee N; Schneider M; Namer M; Boublil JL; Lalanne CM
Cancer Chemother Pharmacol; 1983; 11(1):29-32. PubMed ID: 6883624
[TBL] [Abstract][Full Text] [Related]
22. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
23. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
24. Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate.
Fabresse N; Devictor B; Pissier C; Chambost H; Lacarelle B; Michel G; Solas C
Ther Drug Monit; 2018 Feb; 40(1):76-83. PubMed ID: 29120974
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis.
Kuo CY; Wu HL; Kou HS; Chiou SS; Wu DC; Wu SM
J Chromatogr A; 2003 Oct; 1014(1-2):93-101. PubMed ID: 14558615
[TBL] [Abstract][Full Text] [Related]
26. [Investigation on individualized adjustment of target range of high-dose methotrexate].
Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
[TBL] [Abstract][Full Text] [Related]
27. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
[TBL] [Abstract][Full Text] [Related]
28. Ultrafast selective quantification of methotrexate in human plasma by high-throughput MALDI-isotope dilution mass spectrometry.
Meesters RJ; den Boer E; Mathot RA; de Jonge R; van Klaveren RJ; Lindemans J; Luider TM
Bioanalysis; 2011 Jun; 3(12):1369-78. PubMed ID: 21679031
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapy.
Slørdal L; Kolmannskog S; Prytz PS; Moe PJ; Aarbakke J
Pediatr Hematol Oncol; 1986; 3(2):127-34. PubMed ID: 3153222
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.
Buice RG; Evans WE; Karas J; Nicholas CA; Sidhu P; Straughn AB; Meyer MC; Crom WR
Clin Chem; 1980 Dec; 26(13):1902-4. PubMed ID: 7002366
[TBL] [Abstract][Full Text] [Related]
31. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
Refsum H; Wesenberg F; Ueland PM
Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy, side effects and blood concentration monitoring of high-dose methotrexate in treatment of 180 children with acute lymphoblastic leukemia].
Wang H; Chi ZF; Li S; Wang XL; Hao LC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):949-52. PubMed ID: 21867621
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography.
Albertioni F; Pettersson B; Beck O; Rask C; Seideman P; Peterson C
J Chromatogr B Biomed Appl; 1995 Mar; 665(1):163-70. PubMed ID: 7795788
[TBL] [Abstract][Full Text] [Related]
35. Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.
Beck O; Seideman P; Wennberg M; Peterson C
Ther Drug Monit; 1991 Nov; 13(6):528-32. PubMed ID: 1771651
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay.
Dusci LJ; Hackett LP; Chiswell GM; Ilett KF
Ther Drug Monit; 1992 Aug; 14(4):327-32. PubMed ID: 1519308
[TBL] [Abstract][Full Text] [Related]
37. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
Descoeur J; Dupuy AM; Bargnoux AS; Cristol JP; Mathieu O
J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
[TBL] [Abstract][Full Text] [Related]
38. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia.
Ylinen E; Jahnukainen K; Saarinen-Pihkala UM; Jahnukainen T
Pediatr Blood Cancer; 2014 Dec; 61(12):2199-202. PubMed ID: 25174822
[TBL] [Abstract][Full Text] [Related]
39. CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group.
Milano G; Thyss A; Serre Debeauvais F; Laureys G; Benoit Y; Deville A; Dutour C; Robert A; Otten J; Behar C
Eur J Cancer; 1990 Apr; 26(4):492-5. PubMed ID: 2141516
[TBL] [Abstract][Full Text] [Related]
40. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]